Vistagen Therapeutics Inc (VTGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VTGN Annual Balance Sheets →
Examining balance sheet movements between Vistagen Therapeutics Inc and Jun 30 2025 reveals how Jun 30 2026 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent31.70
Available-for-sale Securities, Debt Securities, Current MA14.74
Cash & Short-term Investments45.00
Prepaid Expense And Other Assets Current2.58
Total Current Assets34.31
Equipment/Property/Plant Net0.38
Other Assets, Noncurrent1.05
Total Assets35.74
Liabilities
Accounts Payable, Current AC1.00
Accrued Liabilities, Current AC9.24
Notes Payable, Current NO0.00
Other Liabilities, Current0.95
Total Current Liabilities11.19
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.06
Total Liabilities11.26
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock518.76
Retained Earnings / Accumulated Deficit-490.35
Accumulated Other Comprehensive Income-0.01
Other Equity-0.01
Common Stockholder's Equity24.48
Total Stockholder's Equity24.48
Liabilities & Stockholder's Equity35.74
4 historic quarters locked

Sign in to unlock the full Vistagen Therapeutics Inc balance sheet history.

About Vistagen Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-057116

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.